Price
Target price
€5.43
€5.43
-2.270%
-0.127
-2.270%
€8.24
18.07.25 / Tradegate
WKN: A2JQ1X / Symbol: BHC / Name: Bausch Health Companies / Stock / Pharmaceuticals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bausch Health Companies Inc. Stock
We can see a decrease in the price for Bausch Health Companies Inc.. Compared to yesterday it has lost -€0.127 (-2.270%).
Currently there is a rather positive sentiment for Bausch Health Companies Inc. with 3 Buy predictions and 0 Sell predictions.
As a result the target price of 8 € shows a positive potential of 47.25% compared to the current price of 5.43 € for Bausch Health Companies Inc..
For the coming years our community has positive and negative things to say abot the Bausch Health Companies Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Revenue growth" there were negative voices in the community.
Pros and Cons of Bausch Health Companies Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
S********** s********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bausch Health Companies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bausch Health Companies Inc. | -2.270% | -4.231% | 0.798% | -22.074% | -25.289% | -36.187% | -65.575% |
| Repligen Corp. | -6.540% | -8.861% | -2.411% | -19.273% | -28.560% | -36.810% | -14.802% |
| Opko Health Inc. | 2.650% | 3.167% | 1.677% | -15.229% | -17.927% | -58.088% | -67.391% |
| Amicus Therapeutics Inc. | 13.860% | 8.491% | 15.462% | -40.104% | -37.158% | -45.928% | -56.767% |
Comments
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Jefferies Financial Group Inc. from $13.00 to $9.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat